Cargando…
IgY Antibodies as Biotherapeutics in Biomedicine
Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and the treatment of multiple diseases. Antibodies are r...
Autores principales: | León-Núñez, Diana, Vizcaíno-López, María Fernanda, Escorcia, Magdalena, Correa, Dolores, Pérez-Hernández, Elizabeth, Gómez-Chávez, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590010/ https://www.ncbi.nlm.nih.gov/pubmed/36278615 http://dx.doi.org/10.3390/antib11040062 |
Ejemplares similares
-
IgY antibodies in human nutrition for disease prevention
por: Müller, Sandra, et al.
Publicado: (2015) -
IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
por: Abbas, Aymn Talat, et al.
Publicado: (2018) -
Use of IgY Antibodies in Human and Veterinary Medicine
por: Schade, Rudiger, et al.
Publicado: (2007) -
Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma
por: Chavez-Cortez, Elda-Georgina, et al.
Publicado: (2019) -
Evaluation of IgY Antibody as a Polyspecific Coombs-Reagent
por: Calzado, Esteban Justo Gutiérrez, et al.
Publicado: (2017)